Data availability statement The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation. Ethics statement The study was performed in compliance with all relevant ethical regulations and the protocol was approved by local Ethical Committee for Clinical experimentation of Regione Toscana Area Vasta Sud Est (CEASVE), protocol code 19479 PATOVAC COV v1.0, approved on March 15th 2021, and protocol code 18869 IMMUNO_COV v1.0, approved on November 18th 2020. The patients/participants provided their written informed consent to participate in this study. Supplementary material The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2022.1017863/full#supplementary-material